PSS World Medical (Nasdaq: PSSI) is expected to report Q2 earnings on Oct. 25. Here's what Wall Street wants to see:

The 10-second takeaway
 Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict PSS World Medical's revenues will compress -17.9% and EPS will decrease -21.6%.

The average estimate for revenue is $428.6 million. On the bottom line, the average EPS estimate is $0.29.

Revenue details
 Last quarter, PSS World Medical reported revenue of $409.4 million. GAAP reported sales were 7.6% higher than the prior-year quarter's $380.5 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 Last quarter, non-GAAP EPS came in at $0.18. GAAP EPS of $0.22 for Q1 were 12% lower than the prior-year quarter's $0.25 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
 For the preceding quarter, gross margin was 33.3%, 110 basis points better than the prior-year quarter. Operating margin was 5.2%, about the same as the prior-year quarter. Net margin was 2.6%, 110 basis points worse than the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $1.72 billion. The average EPS estimate is $1.11.

Investor sentiment
 The stock has a one-star rating (out of five) at Motley Fool CAPS, with 62 members out of 74 rating the stock outperform, and 12 members rating it underperform. Among 26 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 22 give PSS World Medical a green thumbs-up, and four give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on PSS World Medical is hold, with an average price target of $21.19.